Forest's Saunders ropes 2nd major sale, boosts personal brand in Actavis deal

Forest Laboratories president and CEO Brent Saunders has positioned himself as a most-wanted man in the biopharma industry with his second multibillion-dollar sale of a specialty pharmaceutical company in less than a year.